“Sara Tylosky, CEO Farmacon Global presented ‘Challenges and Opportunities: Enrolling Patients in Clinical Trials in Latin America’ at DIA Global Meeting in Chicago, Illinois on June 22nd, 2022, and in reviewing the results of the effectiveness of her presentation provided by DIA Global, we see she received an excellent score from attendees,” said Luis Squiquera MD, CMO Farmacon Global, an MD specialized in Infectious Diseases. Dr. Squiquera’s experience in Latin America in all aspects of clinical trials with Farmacon Global, including patient enrollment across multiple countries, helped Tylosky form her presentation to DIA. Dr. Squiquera obtained his degree from the Medical School at the University of Buenos Aires with post doctorate studies at Johns Hopkins University (Baltimore, MD).
The presentation’s juxtaposition of two very different studies highlighted how Latin America is a viable answer to clinical trial challenges whether for the study of an ultra-rare disease requiring less than 30 patients worldwide of which 80% came from Latin America, or whether ramping-up to enroll 19,000 volunteers across 32 sites, almost doubling the scope of the project.
“I’m happy those who attended my DIA Global presentation said that as a result they had confidence in the future development of the landscape of these markets and felt they had gained new insights and strategies from my presentation’s topic concerning challenges and opportunities of enrolling patients in clinical trials in Latin America,” said Tylosky. “It’s important for anyone considering a clinical trial to know that Latin American is a region of 660 million people and it is a land of opportunity for clinical research and market access with an epidemiological profile resembling that of the Unites States. Navigating the unique cultural and logistical challenges of Latin America and emerging markets is our specialty.”
Tylosky will be happy to provide this presentation with necessary customization to your organization. Contact info: Sara Tylosky, CEO Farmacon Global
